High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of recurrent glioblastoma

Jessica Taylor, Brian Bigger, Omar Pathmanaban et al.|Neuro-Oncology|2018

Cited by 0